Financial Times (ft.com), By Clive Cookson, Nov.13, 2014
Regenerative medicine offers life-changing diabetes treatment – FT.com
The Medtech Strategist, By Mary Thomson, Nov. 13, 2014
Researchers have engineered novel devices to house and protect insulin-secreting beta cells inside the body, and they are combining that technology with human stem cell-derived or even animal-derived beta cells. Their aim is to construct what is essentially a bioartificial pancreas, supplied with readily available lab-grown cells and designed to restore normal, or near-normal, insulin production and glucose regulation to patients with type 1 diabetes.
Biopharma-Reporter.com, By Zachary Brennan, Nov. 11, 2014
Regenerative medicine company ViaCyte has been granted a US patent for the manufacture of human pancreatic progenitor cells from definitive endoderm cells.
CBS8.com, By Steve Price, Nov. 8, 2014
Every year, 145 children in San Diego are diagnosed with type 1 juvenile diabetes. This Saturday, the walk sets out to raise money to hopefully one day find a cure, and some of that money is going to a local company that is currently working on a major medical breakthrough.
ViaCyte calls it a functional cure. You’ll still have diabetes, but you won’t have to keep monitoring your insulin levels multiple times a day.